TFFP
Tff Pharmaceuticals Inc

1,665
Loading...
Loading...
News
all
press releases
Could Netflix become an aggregator of linear channels?
Investing.com -- Netflix’s new partnership with French broadcaster Television Francaise 1 SA (EPA:TFFP) to carry live content on its platform has sparked speculation about the company’s potential role as an aggregator of linear channels.
investing.com·3mo ago
News Placeholder
More News
News Placeholder
TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration
TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration PR Newswire FOXBOROUGH...
PR Newswire·7mo ago
News Placeholder
TFF Pharmaceuticals Full Year 2023 Earnings: Misses Expectations
TFF Pharmaceuticals ( NASDAQ:TFFP ) Full Year 2023 Results Key Financial Results Net loss: US$21.2m (loss narrowed by...
Simply Wall St·1y ago
News Placeholder
TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips TFFP stock results show that TFF Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the fourth...
InvestorPlace·1y ago
News Placeholder
TFF Pharmaceuticals reports Q4 EPS ($2.01) vs. ($6.13) last year
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
FORT WORTH, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) ( the Company ), a clinical-stage biopharmaceutical company focused on developing and commercializing...
Globe Newswire·1y ago
News Placeholder
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Short Interest Update
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest...
Ticker Report·1y ago
News Placeholder
TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs
Eight of Eight Patients Successfully Transitioned from Oral Tacrolimus to TFF TAC with No Sign of Acute Rejection at Reduced Systemic Exposures Data from TFF VORI Phase 2 and EAP Program Continue to...
Globe Newswire·1y ago
News Placeholder
TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (I
Oral Presentation to Present Updated Data from Phase 2 Trial Demonstrating Successful Transition of Patients from Oral Tacrolimus to TFF TACFORT WORTH, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- TFF...
Globe Newswire·1y ago
News Placeholder
TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
FORT WORTH, Texas, March 22, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the Company or TFF Pharmaceuticals ), a clinical-stage biopharmaceutical company focused on...
Globe Newswire·1y ago

Latest TFFP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.